The Big Business of Swine Flu
Americans are still debating whether to roll up their sleeves for a swine flu shot, but companies have already figured it out: vaccines are good for business.
Drug companies have sold $1.5 billion worth of swine flu shots, in addition to the $1 billion for seasonal flu they booked earlier this year. These inoculations are part of a much wider and rapidly growing $20 billion global vaccine market.
Full Story »
A recent article suggests that the 1918 epidemic (which severely affected one of my uncles) was severely aggravated by huge doses of aspirin, which had just been widely introduced. Autopsies showed lung effects not severe enough to cause death, but clear symptoms of aspirin overdose.